SecBot SecBot
EFFECT ·Filed Jun 15, 2026

EOLS

Evolus, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed4mo ago SEC9999999995-26-001986
IPO/offering going effective
Actionable Insight • Neutral

No immediate trading catalyst — monitor for a prospectus supplement (424B5) which would signal an actual takedown. With analyst sentiment 85% bullish and the stock up strongly on prior neutral reads, any announced offering could create a short-term overhang. Position sizing should account for potential near-term dilution if management moves to raise cash.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
EOLS ▲ +26.96% at T+60d
NEUTRAL call +26.96% · α vs SPY +25.96% · entry $6.75 → $8.57
Entry = T+0 close
Jun 15, 2026
via day close
T+1d
-1.78%
call -1.78% · α -1.18%
$6.63
settled 4mo ago
T+5d
-2.37%
call -2.37% · α -0.99%
$6.59
settled 4mo ago
T+20d
-3.41%
call -3.41% · α -2.66%
$6.52
settled 3mo ago
T+60d
+26.96%
call +26.96% · α +25.96%
$8.57
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Evolus's S-3 shelf registration (File No. 333-296556) went effective on June 12, 2026, enabling the company to conduct offerings of up to $250M in securities (common, preferred, debt, warrants, units, rights), including $195.5M carried forward from the prior shelf. This is a routine procedural step following the filing 10 days ago — no concurrent offering has been announced, but the effective shelf creates a potential dilution overhang that the market may price in.

Key Facts

  • S-3 shelf registered up to $250M in securities including $195.5M carried forward from expiring 2023 shelf
  • Effectiveness date: June 12, 2026
  • No concurrent offering or takedown announced with this effectiveness notice
  • Shelf provides capital-raising flexibility for three years

Financial Impact

No immediate dollar impact — shelf provides capacity for up to $250M in future offerings; $195.5M carried forward from prior shelf

dilution potentialcapital structure flexibilityshare count uncertainty

Risk Factors

  • Future offering could dilute existing shareholders if priced below current levels
  • No stated use of proceeds — if cash is raised without clear growth plans, market may view negatively
  • Overhang from shelf capacity may cap near-term upside until company clarifies intentions

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001986
Document: 9999999995-26-001986-index.html9999999995-26-001986
Document: 9999999995-26-001986.txt9999999995-26-001986
8 reports for EOLS
Performance horizon
100% Hit rate @ T+1 4 of 4 directional calls Went positive at some point 4 of 4 best @ T+60▲ +17.82%Jul 8, 2026
Filters
Rows
Reports for EOLS — sortable, filterable
TypeNow
Aug 13, 2026
10w ago
Institutional Cluster
BULLISH ★ 5/10
$8.02 $8.16▲ +1.68%▲ +1.88%$7.17 (−10.60%)
Aug 4, 2026
11w ago
8-K
NEUTRAL ★ 4/10
$6.12 $6.18▲ +0.98%▲ +1.18%$7.17 (+17.16%)
Jul 8, 2026
15w ago
8-K
BULLISH ★ 6/10
$6.79 $6.85▲ +0.88%▲ +0.04%$7.17 (+5.60%)
Jun 15, 2026
19w ago
EFFECT
NEUTRAL ★ 3/10
$6.75 $6.63▼ −1.78%▼ −1.18%$7.17 (+6.22%)
Jun 5, 2026
20w ago
S-3
NEUTRAL ★ 3/10
$6.68 $6.70▲ +0.30%▲ +0.59%$7.17 (+7.34%)
Apr 29, 2026
25w ago
DEFA14A
NEUTRAL ★ 3/10
$5.18 $5.39▲ +4.05%▲ +3.03%$7.17 (+38.42%)
Mar 17, 2026
32w ago
Insider Cluster
BEARISH ★ 6/10
$4.91 $4.83▲ +1.63%▲ +0.23%$7.17 (−46.03%)
Mar 17, 2026
32w ago
Insider Cluster
BEARISH ★ 7/10
$4.91 $4.83▲ +1.63%▲ +0.23%$7.17 (−46.03%)
Showing 8 of 8

US Market Status

Market Closed — Opens Wed (10h 17m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 15, 2026